595 related articles for article (PubMed ID: 30041488)
1. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
Araki M; Nakagawa Y; Oishi A; Han SI; Wang Y; Kumagai K; Ohno H; Mizunoe Y; Iwasaki H; Sekiya M; Matsuzaka T; Shimano H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041488
[TBL] [Abstract][Full Text] [Related]
2. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
[TBL] [Abstract][Full Text] [Related]
3. Saponins from stems and leaves of Panax ginseng prevent obesity via regulating thermogenesis, lipogenesis and lipolysis in high-fat diet-induced obese C57BL/6 mice.
Chen G; Li H; Zhao Y; Zhu H; Cai E; Gao Y; Liu S; Yang H; Zhang L
Food Chem Toxicol; 2017 Aug; 106(Pt A):393-403. PubMed ID: 28599882
[TBL] [Abstract][Full Text] [Related]
4. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
[TBL] [Abstract][Full Text] [Related]
5. Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.
Honda Y; Kessoku T; Ogawa Y; Tomeno W; Imajo K; Fujita K; Yoneda M; Takizawa T; Saito S; Nagashima Y; Nakajima A
Sci Rep; 2017 Feb; 7():42477. PubMed ID: 28195199
[TBL] [Abstract][Full Text] [Related]
6. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
Dong T; Lyu J; Imachi H; Kobayashi T; Fukunaga K; Sato S; Ibata T; Yoshimoto T; Yonezaki K; Iwama H; Zhang G; Murao K
Eur J Pharmacol; 2018 Nov; 838():78-84. PubMed ID: 30201376
[TBL] [Abstract][Full Text] [Related]
7. L-Carnitine Is Involved in Hyperbaric Oxygen-Mediated Therapeutic Effects in High Fat Diet-Induced Lipid Metabolism Dysfunction.
Yuan J; Jiang Q; Song L; Liu Y; Li M; Lin Q; Li Y; Su K; Ma Z; Wang Y; Liu D; Dong J
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906305
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.
Yokote K; Yamashita S; Arai H; Araki E; Suganami H; Ishibashi S; Of The K-Study Group OB
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736366
[TBL] [Abstract][Full Text] [Related]
9. Ethanolic extract of seabuckthorn (Hippophae rhamnoides L) prevents high-fat diet-induced obesity in mice through down-regulation of adipogenic and lipogenic gene expression.
Pichiah PB; Moon HJ; Park JE; Moon YJ; Cha YS
Nutr Res; 2012 Nov; 32(11):856-64. PubMed ID: 23176796
[TBL] [Abstract][Full Text] [Related]
10. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
[TBL] [Abstract][Full Text] [Related]
11. Pemafibrate, a selective PPARα modulator, and fenofibrate suppress microglial activation through distinct PPARα and SIRT1-dependent pathways.
Ogawa K; Yagi T; Guo T; Takeda K; Ohguchi H; Koyama H; Aotani D; Imaeda K; Kataoka H; Tanaka T
Biochem Biophys Res Commun; 2020 Apr; 524(2):385-391. PubMed ID: 32005522
[TBL] [Abstract][Full Text] [Related]
12. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
Lee MS; Kim CT; Kim Y
Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
[TBL] [Abstract][Full Text] [Related]
13. Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases.
Yamashita S; Masuda D; Matsuzawa Y
J Atheroscler Thromb; 2019 May; 26(5):389-402. PubMed ID: 30930344
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression Profiles Induced by a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα) Pemafibrate.
Sasaki Y; Raza-Iqbal S; Tanaka T; Murakami K; Anai M; Osawa T; Matsumura Y; Sakai J; Kodama T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766193
[TBL] [Abstract][Full Text] [Related]
15. Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα.
Yamamoto Y; Takei K; Arulmozhiraja S; Sladek V; Matsuo N; Han SI; Matsuzaka T; Sekiya M; Tokiwa T; Shoji M; Shigeta Y; Nakagawa Y; Tokiwa H; Shimano H
Biochem Biophys Res Commun; 2018 May; 499(2):239-245. PubMed ID: 29567478
[TBL] [Abstract][Full Text] [Related]
16. Melinjo (Gnetum gnemon L.) seed extract induces uncoupling protein 1 expression in brown fat and protects mice against diet-induced obesity, inflammation, and insulin resistance.
Yoneshiro T; Kaede R; Nagaya K; Saito M; Aoyama J; Elfeky M; Okamatsu-Ogura Y; Kimura K; Terao A
Nutr Res; 2018 Oct; 58():17-25. PubMed ID: 30340811
[TBL] [Abstract][Full Text] [Related]
17. Unripe
Kim KJ; Jeong ES; Lee KH; Na JR; Park S; Kim JS; Na CS; Kim YR; Kim S
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339214
[TBL] [Abstract][Full Text] [Related]
18. The Effects of New Selective PPAR
Tang S; Wu F; Lin X; Gui W; Zheng F; Li H
J Diabetes Res; 2020; 2020():4179852. PubMed ID: 32455134
[TBL] [Abstract][Full Text] [Related]
19. Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.
Fruchart JC
Cardiovasc Diabetol; 2017 Oct; 16(1):124. PubMed ID: 28978316
[TBL] [Abstract][Full Text] [Related]
20. Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.
Takei K; Nakagawa Y; Wang Y; Han SI; Satoh A; Sekiya M; Matsuzaka T; Shimano H
J Pharmacol Sci; 2017 Apr; 133(4):214-222. PubMed ID: 28366492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
